Cargando…

Predictors of response to opicinumab in acute optic neuritis

OBJECTIVE: The objective of this study was to evaluate prespecified and post hoc analyses in RENEW subgroups to identify participants more likely to benefit from opicinumab. METHODS: RENEW assessed the efficacy/safety of opicinumab versus placebo in participants with a first unilateral acute optic n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cadavid, Diego, Balcer, Laura, Galetta, Steven, Aktas, Orhan, Ziemssen, Tjalf, Vanopdenbosch, Ludo J., Leocani, Letizia, Freedman, Mark S., Plant, Gordon T., Preiningerova, Jana Lizrova, Ziemssen, Focke, Massacesi, Luca, Chai, Yi, Xu, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186935/ https://www.ncbi.nlm.nih.gov/pubmed/30349850 http://dx.doi.org/10.1002/acn3.620

Ejemplares similares

Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential
por: Klistorner, Alexander, et al.
Publicado: (2018)

Initial Impairment and Recovery of Vision-Related Functioning in Participants With Acute Optic Neuritis From the RENEW Trial of Opicinumab
por: Petrillo, Jennifer, et al.
Publicado: (2019)

Do eyes with and without optic neuritis in multiple sclerosis age equally?
por: Lizrova Preiningerova, Jana, et al.
Publicado: (2018)

Acute optic neuritis: Unmet clinical needs and model for new therapies
por: Galetta, Steven L., et al.
Publicado: (2015)

Interdisziplinäre Kommunikation: Augenarztbriefe an diabetologische Schwerpunktpraxen (DSP)
por: Stock, Lydia, et al.
Publicado: (2020)

Patients’ preferences for involvement in the decision-making process for treating diabetic retinopathy
por: Marahrens, Lydia, et al.
Publicado: (2017)

Anti-Vascular endothelial growth factor therapy impairs endothelial function of retinal microcirculation in colon cancer patients – an observational study
por: Reimann, Manja, et al.
Publicado: (2013)

Bevacizumab: Off-label use in ophthalmology
por: Grisanti, Salvatore, et al.
Publicado: (2007)

Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world
por: Ziemssen, Tjalf, et al.
Publicado: (2017)

The Investigation of the Cardiovascular and Sudomotor Autonomic Nervous System—A Review
por: Ziemssen, Tjalf, et al.
Publicado: (2019)

Why Cognitive–Cognitive Dual-Task Testing Assessment Should Be Implemented in Studies on Multiple Sclerosis and in Regular Clinical Practice
por: Beste, Christian, et al.
Publicado: (2020)

Digital Innovation in Multiple Sclerosis Management
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing–remitting multiple sclerosis converting to glatiramer acetate
por: Ziemssen, Tjalf, et al.
Publicado: (2015)

The Change of Fingolimod Patient Profiles over Time: A Descriptive Analysis of Two Non-Interventional Studies PANGAEA and PANGAEA 2.0
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Importance of Treatment Duration: Unmasking Barriers and Discovering the Reasons for Undertreatment of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration
por: Sobolewska, Bianka, et al.
Publicado: (2021)

Morphology of foveal hypoplasia: Hyporeflective zones in the Henle fiber layer of eyes with high-grade foveal hypoplasia
por: Bringmann, Andreas, et al.
Publicado: (2022)

The PANGAEA study design – a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
por: Ziemssen, Tjalf, et al.
Publicado: (2015)

Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

Fatigue and Sleep in Multiple Sclerosis Patients: A Comparison of Self-Report and Performance-Based Measures
por: Paucke, Madlen, et al.
Publicado: (2018)

The importance of collecting structured clinical information on multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

Spectral Analysis of Heart Rate Variability: Time Window Matters
por: Li, Kai, et al.
Publicado: (2019)

Molecular biomarkers in multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2019)

Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
por: Moser, Tobias, et al.
Publicado: (2022)

Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding site
por: Hanf, Karl J. M., et al.
Publicado: (2020)

Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol
por: Vormfelde, Stefan Viktor, et al.
Publicado: (2016)

Editorial: Cognitive Disorders in Neuroimmunological Diseases
por: Ziemssen, Tjalf, et al.
Publicado: (2020)

Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5)
por: Lizrova Preiningerova, Jana, et al.
Publicado: (2015)

Grundlagen der Replikation und der Immunologie von SARS-CoV-2
por: Ueffing, Marius, et al.
Publicado: (2020)

Impurities in Drug Vials Intended for Intravitreal Medication
por: Pohl, Lisa, et al.
Publicado: (2020)

Biofeedback Based Home Balance Training can Improve Balance but Not Gait in People with Multiple Sclerosis
por: Novotna, Klara, et al.
Publicado: (2019)

Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2008)

Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease
por: Thomas, Katja, et al.
Publicado: (2014)

Dual-Tasking in Multiple Sclerosis – Implications for a Cognitive Screening Instrument
por: Beste, Christian, et al.
Publicado: (2018)

An Innovative Technique to Assess Spontaneous Baroreflex Sensitivity with Short Data Segments: Multiple Trigonometric Regressive Spectral Analysis
por: Li, Kai, et al.
Publicado: (2018)

Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies
por: Akgün, Katja, et al.
Publicado: (2019)

Data Collection in Multiple Sclerosis: The MSDS Approach
por: Ziemssen, Tjalf, et al.
Publicado: (2020)

Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study
por: Schriefer, Dirk, et al.
Publicado: (2020)

Fingolimod Leads to Immediate Immunological Changes Within 6 h After First Administration
por: Sehr, Tony, et al.
Publicado: (2020)

Lymphocyte Counts and Multiple Sclerosis Therapeutics: Between Mechanisms of Action and Treatment-Limiting Side Effects
por: Fischer, Stefanie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ao48t6s8vv93qhrrgccsjo05ei